<![CDATA[Tiziana Life Sciences plc 보도자료 - 뉴스와이어]]>https://www.newswire.co.kr/?md=A10&act=article&no=32124>Mon, 04 May 2026 09:16:01 +0900Copyright (c) 2004~2026 Korea Newswire All rights reservedko-KR<![CDATA[Tiziana Completes Patient Enrollment in a Phase 2a Trial to Evaluate Tolerability and Anti-Tumor Activity of Milciclib in Hepatocellular Carcinoma (HCC)]]>https://www.newswire.co.kr/newsRead.php?no=880046Tue, 04 Dec 2018 11:55:00 +0900<![CDATA[티지아나 라이프 사이언스, 2a상 임상시험 환자등록 완료… HCC 대상 밀시클립의 내약성 및 항종양작용 평가 예정]]>https://www.newswire.co.kr/newsRead.php?no=880048Tue, 04 Dec 2018 11:55:00 +0900